文献速递心脑血管急症重症综合管理与镇静镇痛

心脏骤停后出院时神经功能恢复与长期生存

Neurologic Recovery at Discharge and Long-Term Survival After Cardiac Arrest.
PubMed 文献 · JAMA Netw Open · 2024-10-01
一句话结论心脏骤停存活超30天者,出院时CPC 1完全神经恢复与更好长期生存相关;CPC 2和CPC 3-4死亡风险分别增高57%和146%。

该队列研究利用瑞典4个国家登记库,纳入2010年1月至2019年12月心脏骤停后存活超过30天且出院时完成CPC评估的成人9390例,分为CPC 1(7374例,78.5%)、CPC 2(1358例,14.5%)和CPC 3-4(658例,7.0%)三组。5年生存率CPC 1为73.8%(95%CI 72.5%-75.0%),CPC 2为64.7%(95%CI 62.4%-67.0%),CPC 3-4为54.2%(95%CI 50.6%-57.8%)。与CPC 1相比,CPC 2死亡风险aHR 1.57(95%CI 1.40-1.75),CPC 3-4死亡风险aHR 2.46(95%CI 2.13-2.85)。院外和院内心脏骤停亚组关联相似。出院时神经功能状态可用于长期预后分层。

要点

  • 心脏骤停后存活超30天者中,出院CPC 1占78.5%(7374例),CPC 2占14.5%(1358例),CPC 3-4占7.0%(658例)。
  • 5年生存率:CPC 1为73.8%(95%CI 72.5%-75.0%),CPC 2为64.7%(95%CI 62.4%-67.0%),CPC 3-4为54.2%(95%CI 50.6%-57.8%)。
  • 与CPC 1相比,CPC 2死亡风险aHR 1.57(95%CI 1.40-1.75),CPC 3-4死亡风险aHR 2.46(95%CI 2.13-2.85)。
  • 院外和院内心脏骤停亚组中,出院CPC与长期生存的关联相似。

适用人群与场景

  • 瑞典成人,经历院内心脏骤停或院外心脏骤停后存活超过30天,且在出院时由医疗专业人员完成CPC评估,纳入时间为2010年1月至2019年12月。

诊断标准与关键阈值

  • 神经功能评估采用脑功能分类(CPC)量表,在出院时进行;分组标准:CPC 1为完全恢复,CPC 2为中度残疾,CPC 3-4为重度残疾。

研究设计与关键结果

  • 研究设计:基于瑞典4个强制性国家登记库的队列研究,覆盖全国10年数据,纳入9390例心脏骤停存活者,中位年龄69.0岁(IQR 58.0-77.0),男性6544例(69.7%)。
  • 主要终点:与CPC 1相比,CPC 2死亡风险aHR 1.57(95%CI 1.40-1.75),CPC 3-4死亡风险aHR 2.46(95%CI 2.13-2.85)。
  • 5年生存率:CPC 1为73.8%(95%CI 72.5%-75.0%),CPC 2为64.7%(95%CI 62.4%-67.0%),CPC 3-4为54.2%(95%CI 50.6%-57.8%)。
  • 亚组分析:院外心脏骤停和院内心脏骤停组中,出院CPC与长期生存的关联相似。

证据类型、等级与局限

  • 证据类型:基于全国登记库的队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于心脏骤停后存活超过30天的患者,出院时CPC 1(完全神经恢复)与更好的长期生存相关,而CPC 2或CPC 3-4与更高的长期死亡风险相关。
  • 出院时CPC评估可用于长期预后分层;院外和院内心脏骤停患者中关联相似。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Brain injury is the leading cause of death following cardiac arrest and is associated with severe neurologic disabilities among survivors, with profound implications for patients and their families, as well as broader societal impacts. How these disabilities affect long-term survival is largely unknown.

OBJECTIVE: To investigate whether complete neurologic recovery at hospital discharge after cardiac arrest is associated with better long-term survival compared with moderate or severe neurologic disabilities.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study used data from 4 mandatory national registers with structured and predefined data collection and nationwide coverage during a 10-year period in Sweden. Participants included adults who survived in-hospital cardiac arrest (IHCA) or out-of-hospital cardiac arrest (OHCA) beyond 30 days and who underwent predefined neurologic assessment conducted by health care professionals at hospital discharge using the Cerebral Performance Category (CPC) scale between January 2010 and December 2019. Patients were divided into 3 categories: complete recovery (CPC 1), moderate disabilities (CPC 2), and severe disabilities (CPC 3-4). Statistical analyses were performed in December 2023.

EXPOSURE: CPC score at hospital discharge.

MAIN OUTCOMES AND MEASURES: The primary outcome was long-term survival among patients with CPC 1 compared with those with CPC 2 or CPC 3 or 4.

RESULTS: A total of 9390 cardiac arrest survivors (median [IQR] age, 69 .0 [58.0-77.0] years; 6544 [69.7%] male) were included. The distribution of functional neurologic outcomes at discharge was 7374 patients (78.5%) with CPC 1, 1358 patients (14.5%) with CPC 2, and 658 patients (7.0%) with CPC 3 or 4. Survival proportions at 5 years were 73.8% (95% CI, 72.5%-75.0%) for patients with CPC 1, compared with 64.7% (95% CI, 62.4%-67.0%) for patients with CPC 2 and 54.2% (95% CI, 50.6%-57.8%) for patients with CPC 3 or 4. Compared with patients with CPC 1, there was significantly higher hazard of death for patients with CPC 2 (adjusted hazard ratio [aHR], 1.57 [95% CI, 1.40-1.75]) or CPC 3 or 4 (aHR, 2.46 [95% CI, 2.13-2.85]). Similar associations were seen in the OHCA and IHCA groups.

CONCLUSIONS AND RELEVANCE: In this cohort study of patients with cardiac arrest who survived beyond 30 days, complete neurologic recovery, defined as CPC 1 at discharge, was associated with better long-term survival compared with neurologic disabilities at the same time point.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Dillenbeck E, Svensson L, Rawshani A, et al. Neurologic Recovery at Discharge and Long-Term Survival After Cardiac Arrest. JAMA Netw Open. 2024. PMID: 39392629. doi:10.1001/jamanetworkopen.2024.39196

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。